Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci.

Brandt ER, Teh T, Relf WA, Hobb RI, Good MF.

Infect Immun. 2000 Dec;68(12):6587-94.

PMID:
11083769
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.

Yoonim N, Olive C, Pruksachatkunakorn C, Pruksakorn S.

BMC Microbiol. 2006 Aug 9;6:71.

PMID:
16895610
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.
5.

Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.

Beachey EH, Seyer JM.

J Immunol. 1986 Mar 15;136(6):2287-92.

PMID:
2419429
[PubMed - indexed for MEDLINE]
6.

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF.

Infect Immun. 2003 May;71(5):2373-83.

PMID:
12704107
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF.

Nat Med. 2000 Apr;6(4):455-9.

PMID:
10742155
[PubMed - indexed for MEDLINE]
8.

Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.

Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF.

J Infect Dis. 2006 Jun 15;193(12):1666-76. Epub 2006 May 10.

PMID:
16703510
[PubMed - indexed for MEDLINE]
Free Article
9.

Mapping a conserved conformational epitope from the M protein of group A streptococci.

Relf WA, Cooper J, Brandt ER, Hayman WA, Anders RF, Pruksakorn S, Currie B, Saul A, Good MF.

Pept Res. 1996 Jan-Feb;9(1):12-20.

PMID:
8727479
[PubMed - indexed for MEDLINE]
10.

Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci.

Brandt ER, Hayman WA, Currie B, Pruksakorn S, Good MF.

Vaccine. 1997 Nov;15(16):1805-12.

PMID:
9364687
[PubMed - indexed for MEDLINE]
11.

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.

Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, Hunsakunachai S, Manmontri A, Good MF.

Lancet. 1994 Sep 3;344(8923):639-42.

PMID:
7520963
[PubMed - indexed for MEDLINE]
12.

Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.

Olive C, Sun HK, Ho MF, Dyer J, Horváth A, Toth I, Good MF.

J Infect Dis. 2006 Aug 1;194(3):316-24. Epub 2006 Jun 30.

PMID:
16826479
[PubMed - indexed for MEDLINE]
Free Article
13.

Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities.

Brandt ER, Hayman WA, Currie B, Carapetis J, Jackson DC, Do KA, Good MF.

Int Immunol. 1999 Apr;11(4):569-76.

PMID:
10323210
[PubMed - indexed for MEDLINE]
Free Article
14.

Immunogenicity of a 26-valent group A streptococcal vaccine.

Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB.

Infect Immun. 2002 Apr;70(4):2171-7.

PMID:
11895984
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci.

Pruksakorn S, Currie B, Brandt E, Phornphutkul C, Hunsakunachai S, Manmontri A, Robinson JH, Kehoe MA, Galbraith A, Good MF.

Int Immunol. 1994 Aug;6(8):1235-44.

PMID:
7981150
[PubMed - indexed for MEDLINE]
16.

Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.

Dale JB, Beachey EH.

J Exp Med. 1986 May 1;163(5):1191-202.

PMID:
2422314
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evaluation of synthetic, M type-specific peptides as antigens in a multivalent group A streptococcal vaccine.

Bruner M, James A, Beall B, Carlone GM, Ades E, Johnson S, Guarner J, Sampson J.

Vaccine. 2003 Jun 20;21(21-22):2698-703.

PMID:
12798606
[PubMed - indexed for MEDLINE]
18.

Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines.

Simerska P, Abdel-Aal AB, Fujita Y, Moyle PM, McGeary RP, Batzloff MR, Olive C, Good MF, Toth I.

J Med Chem. 2008 Mar 13;51(5):1447-52. doi: 10.1021/jm701410p. Epub 2008 Feb 16.

PMID:
18278857
[PubMed - indexed for MEDLINE]
20.

Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.

Bronze MS, Courtney HS, Dale JB.

J Immunol. 1992 Feb 1;148(3):888-93.

PMID:
1370521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk